Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 63-71

  Gnana Prakasam, Jaya P ^a   Veeranan Karmegam, Rajalakshmi ^a   Coothankandaswamy, Veena ^a   Reddy, Sushma K ^a   Martin, Pamela M ^a   Thangaraju, Muthusamy ^a   Smith, Sylvia B ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; BETA GALACTOSIDASE; DNA METHYLTRANSFERASE; GLUCOSE; GLUCOSE TRANSPORTER; HFE PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; SURVIVIN; AMINO ACID TRANSPORTER; BIRC5 PROTEIN, MOUSE; CATION TRANSPORT PROTEIN; HFE PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; INHIBITOR OF APOPTOSIS PROTEIN; MEMBRANE PROTEIN; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORTER; REPRESSOR PROTEIN; SLC5A8 PROTEIN, MOUSE; SLC6A14 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIGENETICS; FLOW CYTOMETRY; GENE EXPRESSION; HEMOCHROMATOSIS; HISTONE ACETYLATION; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; TUMOR GROWTH; WESTERN BLOTTING; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL AGING; CELL MOTION; CELL TRANSFORMATION; DISEASE COURSE; DNA METHYLATION; EYE TUMOR; FEMALE; GENETICS; MALE; METABOLISM; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE; XENOGRAFT;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; CATION TRANSPORT PROTEINS; CELL AGING; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA METHYLATION; EYE NEOPLASMS; FEMALE; GLUCOSE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; PHENOTYPE; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PRIMARY CELL CULTURE; REPRESSOR PROTEINS; RETINAL PIGMENT EPITHELIUM; TRANSPLANTATION, HETEROLOGOUS;

MLCS; MLOWN;

EID: 84874544637     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10312     Document Type: Article

References (43)

1. Donovan A, Andrews NC. The molecular regulation of iron metabolism. Hematol J. 2004;5:373-380.
2. Fleming RE, Britton RS, Waheed A, Sly WS, Bacon BR. Pathophysiology of hereditary hemochromatosis. Semin Liver Dis. 2005;25:411-419.
3. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med. 2006;57:331-347.
4. Ganz T, Nemeth E. Hepcidin and regulation of body iron metabolism. Am J Physiol. 2006;290:G199-G203.
5. Fleming RE, Britton RS. Iron Imports. VI. HFE and regulation of intestinal iron absorption. Am J Physiol. 2006;290:G590-G594.
6. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984;219:1-14.
7. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
8. Wallace DF, Subramaniam VN. Non-HFE haemochromatosis. World J Gastroenterol. 2007;13:4690-4698.
9. Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci U S A. 2005;102:12413-12418.
10. Chen H, Lukas TJ, Du N, Suyeoka G, Neufeld AH. Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest Ophthalmol Vis Sci. 2009;50:1895-1902.
11. Dentchev T, Hahn P, Dunaief JL. Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol. 2005;123:1745-1746.
12. Martin PM, Gnana-Prakasam JP, Roon P, Smith RG, Smith SB, Ganapathy V. Expression and polarized localization of the hemochromatosis gene product HFE in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2006;47:4238-4244.
13. Gnana-Prakasam JP, Martin PM, Mysona BA, Roon P, Smith SB, Ganapathy V. Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. Biochem J. 2008;411:79-88.
14. Gnana-Prakasam JP, Martin PM, Zhang M, Atherton SS, Smith SB, Ganapathy V. Expression of the iron-regulatory protein haemojuvelin in retina and its regulation during cytomegalovirus infection. Biochem J. 2009;419:533-543.
15. Hahn P, Qian Y, Dentchev T, et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A. 2004;101:13850-13855.
16. Hadziahmetovic M, Dentchev T, Song Y, et al. Ceruloplasmin/ hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci. 2008;49:2728-2736.
17. Gnana-Prakasam JP, Thangaraju M, Liu K, Martin PM, Smith SB, Ganapathy V. Absence of iron-regulatory protein HFE results in hyperproliferation of retinal pigment epithelium mediated by induction of cystine/glutamate transporter. Biochem J. 2009; 424:243-252.
18. Gnana-Prakasam JP, Tawfik A, Romej M, et al. Iron-mediated retinal degeneration in haemojuvelin-knockout mice. Biochem J. 2011;441:599-608.
19. Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer. 1988;41:677-682.
20. Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 2007;1:19-25.
21. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Ptendeficient tumorigenesis. Nature. 2005;436:725-730.
22. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001;11:S27-S31.
23. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev. 1999;13:239-252.
24. Cheung H, LaCasse EC, Korneluk RG. XIAP antagonism: strategies in cancer treatment. Clin Cancer Res. 2006;12: 3238-3242.
25. Calvo TB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010; 2010;pii:205357.
26. Matsuzu K, Segade F, Matsuzu U, Carter A, Bowden DW, Perrier ND. Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid. 2004;14:806-812.
27. Chan DA, Sutphin PD, Nguyen P, et al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011;3: 94ra70.
28. Mathupala SP, Ko YH, Pedersen PL, Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene. 2006; 25:4777-4786.
29. 0,{thorn}(SLC6A14) in colorectal cancer and metastasis in humans. Biochim Biophys Acta. 2005;1741: 215-223.
30. 0,{thorn}(SLC6A14) in carcinoma of the cervix. Gynecol Oncol. 2006;100:8-13.
31. Ganapathy V, Thangaraju M, Gopal E, et al. Sodium-coupled monocarboxylate transporters in normal tissue and in cancer. AAPS J. 2008;10:193-199.
32. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther. 2009;121:29-40.
33. Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov. 2002;1:287-299.
34. Iizuka M, Smith MM. Functional consequences of histone modifications. Curr Opin Genet Dev. 2003;13:154-160.
35. Rountree MR, Bachman KE, Herman JG, Baylin SB. DNA methylation, chromatin inheritance, and cancer. Oncogene. 2001;20:3156-3165.
36. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3:46-54.
37. Li F. Survivin study: what is the next wave? J Cell Physiol. 2003;197:8-29.
38. Geho DH, Bandle RW, Clair T, Liotta LA. Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda). 2005;20:194-200.
39. Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 2007;1:19-25.
40. Feser J, Truong D, Das C, et al. Elevated histone expression promotes life span extension. Mol Cell. 2010;39:724-735.
41. Hadziahmetovic M, Song Y, Ponnuru P, et al. Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci. 2011;52:109-118.
42. Hadziahmetovic M, Song Y, Wolkow N, et al. Bmp6 regulates retinal iron homeostasis and has altered expression in agerelated macular degeneration. Am J Pathol. 2011;179:335-348.
43. Zhao C, Yasumura D, Li X, et al. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest. 2011;121:369-383.